Literature DB >> 3335292

What is cytoprotection of the gastric mucosa?

W Silen1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3335292     DOI： 10.1016/0016-5085(88)90635-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

Review 1.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

2.  Effects of aging on duodenal bicarbonate secretion.

Authors:  S W Kim; D Parekh; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

3.  Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing.

Authors:  J Folkman; S Szabo; M Stovroff; P McNeil; W Li; Y Shing
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

4.  Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis.

Authors:  R Hernández-Muñoz; F Montiel-Ruíz
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

5.  Prostaglandin E2 and prostaglandin F2 alpha biosynthesis in human gastric mucosa: effect of chronic alcohol misuse.

Authors:  C Bode; G Maute; J C Bode
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

6.  Endothelial cell growth regulation by PGE1 analog misoprostol and indomethacin.

Authors:  T Patrice; J Harb; M T Foultier; A Berrada; N Robillard; J P Galmiche; K Meflah; L Lebodic
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

7.  Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.

Authors:  S M Kelly; J R Jenner; R J Dickinson; J O Hunter
Journal:  Gut       Date:  1994-05       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.